2U3:FRA
Alcon AG
56,96 €
arrow_downward
-0,21%(-0,12) 1D
5 ოქტ, 22:00:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2U3...
Open
56,44 €
High
56,96 €
Low
56,44 €
Mkt. cap
26,46 მლრდ.
Avg. vol.
210,00
Volume
103,00
52-wk high
73,96 €
52-wk low
51,78 €
No. of employees
25 ათ.
Open
56,44 €
High
56,96 €
Low
56,44 €
Mkt. cap
26,46 მლრდ.
Avg. vol.
210,00
Volume
103,00
52-wk high
73,96 €
52-wk low
51,78 €
No. of employees
25 ათ.
News stories
From web sources and news partners
AD HOC NEWS
·
3 საათის წინ
Alcon stock after-hours at EUR 57.18: plus 1.08 percent versus prior close
AD HOC NEWS
·
6 საათის წინ
Alcon stock gets a new weekly lens launch in October 2026
AD HOC NEWS
·
10 საათის წინ
Alcon announces Academy research. Alcon stock sits 23.02 percent below its 52-week high
AD HOC NEWS
·
13 საათის წინ
Alcon stock pre-market at EUR 56.31: minus 0.46 percent
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEOდავიდ ჯეი ენდიკოტ
Employees25 ათ.
Founded1945
Headquartersჟენევა, ჟენევის კანტონი, შვეიცარია
SectorMedical device
Websitealcon.com